Patent ID: 9622950
Date: 2017-04-18
CPC Classifications: A61K,A61P,A61Q

Claim:
1. A transdermal composition for topical administration to a subject having an inflammation-induced dermatological disease or condition, comprising: an effective amount of an active anti-inflammatory agent comprising at least one of dihydroeugenol, a salt of dihydroeugenol, or an ester of dihydroeugenol, wherein the active anti-inflammatory agent is present in a range of from about 0.1% to about 10% by weight of the transdermal composition; and the remainder of the transdermal composition being an aqueous, aqueous mixed, or non-aqueous pharmaceutically-acceptable carrier or vehicle effective in carrying or enabling passage of the active agent into the epidermis or dermis of the skin of the subject where the active agent has its effect on the dermatological disease or dermatological condition.